Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 12 studies | 79% ± 17% | |
| glutamatergic neuron | 9 studies | 44% ± 18% | |
| adipocyte | 9 studies | 40% ± 10% | |
| astrocyte | 8 studies | 37% ± 17% | |
| fibroblast | 8 studies | 21% ± 4% | |
| GABAergic neuron | 7 studies | 34% ± 16% | |
| endothelial cell | 7 studies | 34% ± 20% | |
| oligodendrocyte | 7 studies | 31% ± 15% | |
| mast cell | 7 studies | 24% ± 5% | |
| smooth muscle cell | 7 studies | 21% ± 5% | |
| neuron | 6 studies | 37% ± 15% | |
| macrophage | 6 studies | 29% ± 12% | |
| retinal cone cell | 6 studies | 54% ± 33% | |
| B cell | 6 studies | 30% ± 10% | |
| T cell | 6 studies | 26% ± 7% | |
| interneuron | 5 studies | 45% ± 12% | |
| microglial cell | 5 studies | 34% ± 14% | |
| dendritic cell | 5 studies | 29% ± 6% | |
| myeloid cell | 5 studies | 17% ± 2% | |
| pericyte | 4 studies | 36% ± 14% | |
| monocyte | 4 studies | 44% ± 12% | |
| natural killer cell | 4 studies | 33% ± 5% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 62% ± 6% | |
| epithelial cell | 3 studies | 50% ± 14% | |
| progenitor cell | 3 studies | 36% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 32% ± 3% | |
| non-classical monocyte | 3 studies | 36% ± 19% | |
| GABAergic amacrine cell | 3 studies | 49% ± 5% | |
| glycinergic amacrine cell | 3 studies | 33% ± 9% | |
| retinal pigment epithelial cell | 3 studies | 32% ± 9% | |
| lymphocyte | 3 studies | 43% ± 12% | |
| leukocyte | 3 studies | 38% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 1789.99 | 2601 / 2642 | 98% | 18.19 | 692 / 705 |
| adrenal gland | 100% | 2186.23 | 258 / 258 | 96% | 19.45 | 221 / 230 |
| intestine | 100% | 3383.88 | 966 / 966 | 96% | 8.95 | 504 / 527 |
| esophagus | 100% | 2693.17 | 1445 / 1445 | 92% | 8.24 | 169 / 183 |
| breast | 99% | 2220.78 | 454 / 459 | 91% | 9.70 | 1019 / 1118 |
| thymus | 98% | 1145.12 | 641 / 653 | 90% | 6.66 | 546 / 605 |
| prostate | 98% | 1178.45 | 240 / 245 | 90% | 5.85 | 453 / 502 |
| stomach | 93% | 1442.82 | 333 / 359 | 95% | 9.12 | 271 / 286 |
| skin | 100% | 3772.09 | 1807 / 1809 | 80% | 16.71 | 377 / 472 |
| lung | 99% | 1779.04 | 575 / 578 | 78% | 5.63 | 905 / 1155 |
| pancreas | 80% | 566.45 | 261 / 328 | 96% | 11.97 | 170 / 178 |
| bladder | 100% | 2142.24 | 21 / 21 | 70% | 5.62 | 353 / 504 |
| uterus | 98% | 2756.75 | 166 / 170 | 60% | 5.13 | 274 / 459 |
| ovary | 100% | 1768.27 | 180 / 180 | 24% | 1.13 | 105 / 430 |
| adipose | 100% | 2976.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2322.32 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.24 | 1 / 1 |
| blood vessel | 99% | 1915.74 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 15.97 | 79 / 80 |
| kidney | 40% | 337.19 | 36 / 89 | 54% | 2.66 | 489 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 7.28 | 35 / 45 |
| peripheral blood | 77% | 880.72 | 711 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 5.97 | 22 / 29 |
| heart | 60% | 855.55 | 514 / 861 | 0% | 0 | 0 / 0 |
| muscle | 18% | 119.69 | 144 / 803 | 0% | 0 | 0 / 0 |
| liver | 1% | 7.35 | 3 / 226 | 8% | 0.42 | 32 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0050650 | Biological process | chondroitin sulfate proteoglycan biosynthetic process |
| GO_0030203 | Biological process | glycosaminoglycan metabolic process |
| GO_0015012 | Biological process | heparan sulfate proteoglycan biosynthetic process |
| GO_0030166 | Biological process | proteoglycan biosynthetic process |
| GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
| GO_0048706 | Biological process | embryonic skeletal system development |
| GO_0043931 | Biological process | ossification involved in bone maturation |
| GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0000137 | Cellular component | Golgi cis cisterna |
| GO_0030158 | Molecular function | protein xylosyltransferase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | XYLT1 |
| Protein name | XYLT1 protein Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I) Xylosyltransferase I |
| Synonyms | XT1 |
| Description | FUNCTION: Catalyzes the first step in the biosynthesis of chondroitin sulfate and dermatan sulfate proteoglycans, such as DCN. Transfers D-xylose from UDP-D-xylose to specific serine residues of the core protein . Required for normal embryonic and postnatal skeleton development, especially of the long bones . Required for normal maturation of chondrocytes during bone development, and normal onset of ossification (By similarity). . |
| Accessions | Q86Y38 ENST00000261381.7 A0A0C5BQN3 ENST00000671765.2 A0A0A7KW96 |